Childhood epilepsy: What is the evidence for what we think and what we do?

Journal of Child Neurology

Volumn 18, Issue 4, 2003, Pages 272-287

  Camfield, Peter ^a   Camfield, Carol ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CORTICOTROPIN; DIAZEPAM; ETHOSUXIMIDE; GABAPENTIN; HYDROCORTISONE; LORAZEPAM; METHYLPHENOBARBITAL; MIDAZOLAM; NITRAZEPAM; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; PREDNISOLONE; STIRIPENTOL; SULTIAME; VALPROIC ACID; VIGABATRIN;

ADULT; CHILD; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; CLINICAL TRIAL; COCHRANE LIBRARY; COMPARATIVE STUDY; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE SEVERITY; DRUG EFFICACY; EPILEPSY; EVIDENCE BASED MEDICINE; HUMAN; INTELLECTUAL IMPAIRMENT; INTRACTABLE EPILEPSY; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDLINE; NEUROLOGIC DISEASE; ONSET AGE; PLAY THERAPY; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PUBLICATION; REMISSION; REVIEW; SEIZURE; SIDE EFFECT; SOCIAL ASPECT; TREATMENT FAILURE;

EID: 0037951798     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738030180041401     Document Type: Review

References (119)

1. Academy of Pediatrics Committee On Quality Improvement Sub-committee on Febrile Seizures: Practice parameter: Longterm treatment of the child with simple febrile seizures. Pediatrics 1999;103:1307-1309.
2. Hirtz D, Berg A, Brettis D, et al: Practice parameter: The evaluation of a first non-febrile seizure in children (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55:616-623.
3. Van Donselaar CA, Geerts AT, Meulstee J, et al: Reliability of the diagnosis of a first seizure. Neurology 1989;39:267-271.
4. Stroink H, Brouwer OF, Arts WF, et al: The first unprovoked, untreated seizure in childhood: A hospital based study of the accuracy of the diagnosis, rate of recurrence, and long-term outcome after recurrence. Dutch study of epilepsy in childhood. J Neurol Neurosurg Psychiatry 1998;64:595-600.
5. Smith D, Defalla BA, Chadwick DW: The misdiagnosis of epilepsy and the management of refractory epilepsy in a specialist clinic. Q J Med 1999;92:15-23.
6. Zaidi IA: Misdiagnosis of epilepsy: Many seizure-like attacks have a cardiovascular cause. J Am Coll Cardiol 2000;36:181-184.
7. Berg AT, Shinnar S, Levy SR, Testa FM: Newly diagnosed epilepsy in children: Presentation at diagnosis. Epilepsia 1999;40:445-452.
8. Rugg-Gunn FJ, Harrison NA, Duncan JS: Evaluation of the accuracy of seizure descriptions by the relatives of patients with epilepsy. Epilepsy Res 2001;43:193-199.
9. Bodensteiner JB, Brownsworth RD, Knapik JR, et al: Interobserver variability in the ILAE classification of seizures in childhood. Epilepsia 1988;29:123-128.
10. Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
11. Parra J, Augustijn PB, Geerts Y, van Emde Boas W: Classification of epileptic seizures: A comparison of two systems. Epilepsia 2001;42:476.
12. Lüders H, Noachtar W: Atlas of Epileptic Seizures and Syndromes. Philadelphia, WB Saunders, 2001.
13. Commission on Classification and Terminology of the International League Against Epilepsy: Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489-501.
14. Berg AT, Steinschneider M, Kang H, Shinnar S: Classification of complex features of febrile seizures: Interrater agreement. Epilepsia 1992;33:661-666.
15. Commission on Classification and Terminology of the International League Against Epilepsy: Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-399.
16. Engel J: A proposed diagnostic scheme for people with epileptic seizures and epilepsy: Report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001;42:796-803.
17. King MA, Newton MR, Jackson GD, et al: Epileptology of the first-seizure presentation: A clinical, electroencephalographic, and magnetic resonance imaging study of 300 consecutive patients. Lancet 1998;352:1007-1011.
18. Rinaldi G, Zarrelli MM, Beghi E, et al: The international classification of the epilepsies and epileptic syndromes. An algorithm for its use in clinical practice. Epilepsy Res 2000;41:223-234.
19. Berg AT, Levy SR, Testa FM, Shinnar S: Classification of childhood epilepsy syndromes in newly diagnosed epilepsy: Interrater agreement and reasons for disagreement. Epilepsia 1999;40:439-444.
20. Shinnar S, Berg AT, O'Dell C, et al: Predictors of multiple seizures in a cohort of children prospectively followed from the time of their first unprovoked seizure. Ann Neurol 2000;48:140-147.
21. Berg AT, Shinnar S, Levy SR, et al: How well can epilepsy syndromes be identified at diagnosis?: A reassessment two years after initial diagnosis. Epilepsia 2000;41:1269-1275.
22. Middeldorp CM, Geerts AT, Brouwer OF, et al: Nonsymptomatic generalized epilepsy in children younger than six years: Excellent prognosis, but classification should be reconsidered after follow-up: The Dutch study of epilepsy in childhood. Epilepsia 2002;43:734-739.
23. Shinnar S, O'Dell C, Berg AT: Distribution of epilepsy syndromes in a cohort of children prospectively monitored from the time of their first unprovoked seizure. Epilepsia, 1999;40:1378-1383.
24. Berg AT, Shinnar S: The risk of recurrence following a first unprovoked seizure: A quantitative review. Neurology 1991;41:965-972.
25. Camfield PR, Camfield CS, Dooley JM, et al: Epilepsy after a first unprovoked seizure in childhood. Neurology 1985;35:1657-1660.
26. Hauser WA, Rich SS, Lee JR, et al: Risk of recurrent seizures after two unprovoked seizures. N Engl J Med 1998;338:429-434.
27. Camfield CS, Camfield PR, Gordon KE, et al: Predicting the outcome of childhood epilepsy: A population-based study yielding a simple scoring system. J Pediatr 1993;122:861-868.
28. Sillanpaa M, Jalava M, Kaleva O, Shinnar S: Long-term prognosis of seizures with onset in childhood. N Engl J Med 1998;338:1715-1722.
29. Camfield CS, Camfield PR, Wirrell E, et al: Incidence of epilepsy in childhood and adolescents: A population based study in Nova Scotia from 1977-1985. Epilepsia 1996;37:19-23.
30. Camfield CS, Camfield PR, Veugelers PJ: Death in children with epilepsy: A population-based study. Lancet 2002;359:1891-1895.
31. Sillanpaa M, Camfield PR, Camfield CS: Predicting long-term outcome of childhood epilepsy in Nova Scotia, Canada and Turku Finland: Validation of a simple scoring system. Arch Neurol 1995;52:589-592.
32. Annegers JF, Hauser WA, Elbeback LR: Remission of seizures and relapse in patients with epilepsy. Epilepsia 1979;20:729-737.
33. Brorson LO, Wranne L: Long-term prognosis in childhood epilepsy: Survival and seizure prognosis. Epilepsia, 1987;28:324-330.
34. Cockerell OC, Johnson AL, Sander JW, Shorvon SC: Prognosis of epilepsy: A review and further analysis of the first nine years of the British National General Practice Study of Epilepsy: A prospective population-based study. Epilepsia 1997;38:31-46.
35. Arts WF, Geerts AT, Brouwer OF, et al: The early prognosis of epilepsy in childhood: The prediction of a poor outcome. The Dutch study of epilepsy in childhood. Epilepsia 1999;40:726-734.
36. Berg AT, Shinnar S, Levy SR, et al: Early development of intractable epilepsy in children: A prospective study. Neurology 2001;56:1445-1452.
37. Sillanpaa M: Remission of seizures and prediction of intractability in long-term follow-up. Epilepsia 1993;34:930-936.
38. Huttenlocker PR, Hapke RJ: A follow-up study of intractable seizures in childhood. Ann Neurol 1990;28:699-705.
39. Camfield PR, Camfield CS: Antiepileptic drug therapy: When is epilepsy truly intractable? Epilepsia 1996;37(Suppl 2):S60-S65.
40. Kwan P, Brodie MJ: Early identification of refractory epilepsy. N Engl J Med 2000;342:314-319.
41. Camfield PR, Camfield CS, Gordon K, Dooley JM: If a first antiepileptic drug fails to control a child's epilepsy, what are the chances of success with the next drug. J Pediatr 1997;131:821-824.
42. Wirrell E, Camfield C, Camfield P, Dooley J: Prognostic significance of failure of the initial antiepileptic drug in children with absence epilepsy. Epilepsia, 2001;42:760-763.
43. Camfield CS, Camfield PR, Gordon KE, et al: Biologic factors as predictors of social outcome in epilepsy in intellectually normal children: A population-based study. J Pediatr 1993;122:869-873.
44. Jalava M, Sillanpaa M, Camfield CS, Camfield PR: Social adjustment and competence 35 years after onset of childhood epilepsy: A prospective controlled study. Epilepsia, 1997;38:708-715.
45. Kokkonen J, Kokkonen ER, Saukkonen AL, Pennanen P: Psychosocial outcome of young adults with epilepsy in childhood. J Neurol Neurosurg Psychiatry 1997;62:265-268.
46. Wakamoto H, Nagao H, Hayashi M, Morimoto T: Long-term medical, educational and social prognoses of childhood-onset epilepsy; a population-based study in a rural district of Japan. Brain Dev 2000;22:246-255.
47. Olsson I, Campenshausen A: Social adjustment in young adults with absence epilepsies. Epilepsia 1993;34:846-851.
48. Wirrell EC, Camfield CS, Camfield PR, et al: Long-term psychosocial outcome in typical absence epilepsy: Sometimes a wolf in sheep's clothing. Arch Pediatr Adolesc Med 1997;151:152-158.
49. Austin JK, Huberty TJ, Huster GA, Dunn DW: Academic achievement in children with epilepsy or asthma. Dev Med Child Neurol 1998;40:248-255.
50. Callenbach PM, Westendorp RG, Geerts AT, et al: Mortality risk in children with epilepsy: The Dutch study of epilepsy in childhood. Pediatrics 2001;107:1259-1263.
51. Lhatoo SD, Johnson AL, Goodridge DM, et al: Mortality in epilepsy in the first 11 to 14 years after diagnosis: Multivariate analysis of a long-term, prospective, population-based cohort. Ann Neurol 2001;49:336-344.
52. Donner EJ, Smith CR, Snead OC: Sudden unexplained death in children with epilepsy. Neurology 2001;57:430-434.
53. Canadian Study Group for Childhood Epilepsy: Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Epilepsia 1998;39:952-959.
54. Verity CM, Hosking G, Easter DJ: A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. The Paediatric EPITEG Collaborative Group. Dev Med Child Neurol 1995;37:97-108.
55. Berg AT, Shinnar S: Relapse following discontinuation of antiepileptic drugs: Meta-analysis. Neurology 1994;44:601-608.
56. Dooley JM, Gordon K, Camfield PR, et al: Discontinuation of anticonvulsant therapy in children free of seizures for 1 year. Neurology 1996;46:969-974.
57. Peters AC, Brouwer OF, Geerts AT, et al: Randomized prospective study of early discontinuation of AED's in children with epilepsy. Neurology 1998;50:724-730.
58. Braathen G, Anderson T, Gylie H, et al: Comparison between one and three years of treatment in uncomplicated childhood epilepsy: A prospective study. 1. Outcome in different seizure types. Epilepsia 1996;37:822-832.
59. Sirven JI, Sperling M, Wingerchuk DM: Early versus late antiepileptic drug withdrawal for people with epilepsy in remission, Cochrane Review, in The Cochrane Library, Issue 3. Oxford, Update Software, 2002.
60. Tennison M, Greenwood R, Lewis D, Thorn M: Discontinuing antiepileptic drugs in children with epilepsy: A comparison of a six-week and a nine-month taper period. N Engl J Med 1994;330:1407-1410.
61. Todt H: The late prognosis of epilepsy in childhood: Results of a prospective follow-up study. Epilepsia 1984;25:137-144.
62. Shope JT: Intervention to improve compliance with pediatric anticonvulsant therapy. Pat Couns Health Educ 1980;2:135-141.
63. Lewis MA, Salas I, de la Sota A, et al: Randomized trial of a program to enhance the competencies of children with epilepsy. Epilepsia 1990;31:101-109.
64. Tieffenberg JA, Wood EI, Alonso A, et al: A randomized field trial of ACINDES: A child-centered training model for children with chronic illnesses (asthma and epilepsy). J Urban Health 2000;77:280-297.
65. Bradley P, Lindsay B: Epilepsy clinics versus general neurology or medical clinics, Cochrane Review, in The Cochrane Library, Issue 3. Oxford, Update Software, 2002.
66. Bradley P, Lindsay B: Specialist epilepsy nurses for treating epilepsy, Cochrane Review, in The Cochrane Library, Issue 3. Oxford, Update Software, 2002.
67. Commission on Antiepileptic Drugs, International League Against Epilepsy: Guidelines for therapeutic monitoring on antiepileptic drugs. Epilepsia 1993;34:585-587.
68. Schoenenberger RA, Tanasijevic MJ, Jha A, Bates DW: Appropriateness of antiepileptic drug level monitoring. JAMA 1995;274:1622-1626.
69. Jannuzzi G, Cian P, Fattore C, et al: A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. The Italian TDM Study Group in Epilepsy. Epilepsia 2000;41:222-230.
70. Woo E, Chan YM, Yu YL, et al: If a well-stabilized epileptic patient has a subtherapeutic antiepileptic drug level, should the dose be increased? A randomized prospective study. Epilepsia 1988;29:129-139.
71. Camfield CS, Camfield PR, Smith E, Tibbles JA: Asymptomatic children with epilepsy: Little benefit from screening for anticonvulsant-induced liver, blood or renal damage. Neurology 1986;36:838-841.
72. Camfield PR, Camfield CS, Dooley J, et al: Routine screening of blood and urine for severe reactions to anticonvulsant drugs in asymptomatic patients is of doubtful value. Can Med Assoc J 1989;140:1303-1305.
73. Ronen GM, Rosales TO, Connolly M, et al: Seizure characteristics in chromosome 20 benign familial neonatal convulsions. Neurology 1993;43:1355-1360.
74. Matsumoto A, Watanabe K, Negoro T, et al: Long-term prognosis after infantile spasms: A statistical study of prognostic factors in 200 cases. Dev Med Child Neurol 1981;23:51-65.
75. Riikonen R: A long-term follow-up study of 214 children with the syndrome of infantile spasms. Neuropediatrics 1982;13:14-23.
76. Lee WL, Low PS, Rajan U: Benign familial infantile epilepsy. J Pediatr 1993;123:588-590.
77. Oguni H, Hayashi K, Awaya Y, et al: Severe myoclonic epilepsy in infants - A review based on the Tokyo Women's Medical University series of 84 cases. Brain Dev 2001;23:736-748.
78. Bouma PAD, Bovenkerk AC, Westendorp RGJ, Brouwer OF: The course of benign partial epilepsy of childhood with centro-temporal spikes: A meta-analysis. Neurology 1997;48:430-437.
79. Ferrie CD, Beaumanoir A, Guerrini R, et al: Early-onset benign occipital seizure susceptibility syndrome. Epilepsia 1997;38:285-293.
80. Kivity S, Ephraim T, Wietz R, Tamir A: Childhood epilepsy with occipital paroxysms: Clinical variants in 134 patients. Epilepsia 2000;41:1522-1533.
81. Oguni H, Tanaka T, Hayashi K, et al: Treatment and long-term prognosis of myoclonic-astatic epilepsy of early childhood. Neuropediatrics 2002;33:122-132.
82. Goldsmith IL, Zupanc ML, Buchhalter JR: Long-term seizure outcome in 74 patients with Lennox-Gastaut syndrome: Effects of incorporating MRI head imaging in defining the cryptogenic group. Epilepsia 2000;41:395-399.
83. Rantala H, Putkonen T: Occurrence, outcome, and prognostic factors of infantile spasms and Lennox-Gastaut syndrome. Epilepsia 1999;40:286-289.
84. Oguni H, Hayashi K, Osawa M: Long-term prognosis of Lennox-Gastaut syndrome. Epilepsia 1996;37(Suppl 3):S44-S47.
85. Yagi K: Evolution of Lennox-Gastaut syndrome: A long-term longitudinal study. Epilepsia 1996;37(Suppl 3):48-51.
86. Bouma PAD, Westendorp RGJ, van Dijk JG, et al: The outcome of absence epilepsy: A meta-analysis. Neurology 1996;47:802-813.
87. Wirrell EC, Camfield CS, Camfield PR, et al: Long-term prognosis of typical childhood absence epilepsy: Remission or progression to juvenile myoclonic epilepsy. Neurology 1996;47:912-918.
88. Bartolomei F, Roger J, Bureau M, et al: Prognostic factors for childhood and juvenile absence epilepsies. Eur Neurol 1997;37:169-175.
89. Loiseau P, Douche B, Pedespan JM: Absence epilepsies. Epilepsia 1995;36:1182-1186.
90. Panayiotopoulos CP, Obeid T, Tahan AR: Juvenile myoclonic epilepsy: A 5-year prospective study. Epilepsia 1994;35:285-296.
91. Oldani A, Zucconi M, Asselta R, et al: Autosomal dominant nocturnal frontal lobe epilepsy; a video polysomnographic analysis of 40 patients and delineation of the epileptic syndrome. Brain 1998;121:205-223.
92. Singh R, Scheffer IE, Crossland K, Berkovic SF: Generalized epilepsy with febrile seizures plus: A common childhood-onset genetic epilepsy syndrome. Ann Neurol 1999;45:75-81.
93. Vining EP, Freeman JM, Pillas DJ, et al: Why would you remove half a brain? The outcome of 58 children after hemispherectomy. The Johns Hopkins Experience: 1968 to 1996. Pediatrics 1997;100:163-171.
94. Rasmussen T: Further observations on the syndrome of chronic encephalitis and epilepsy. Appl Neurophysiol 1978;4:1-12.
95. Guerreiro, MM, Vigonius U, Pohlmann H, et al: A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res 1997;27:205-213.
96. Thilothammal N, Banu K, Ratnam RS: Comparison of phenobarbitone, phenytoin with sodium valproate: Randomized, double-blind study. Indian Pediatr 1996;33:549-555.
97. de Silva M, MacArdle B, McGowan M, et al: Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine or sodium valproate for newly diagnosed childhood epilepsy. Lancet 1996;347:709-713.
98. Mitchell WG, Chavez JM: Carbamazepine versus phenobarbital for partial onset seizures in children. Epilepsia 1987;28:56-60.
99. Young RS, Alger PM, Bauer L, Lauderbaugh D: A randomized, double-blind, crossover study of phenobarbital and mephobarbital. J Child Neurol 1986;1:361-363.
100. Pal DK, Das T, Chaudhury G, et al: Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India. Lancet 1998;351:19-23.
101. Forsythe I, Butler R, Berg I, McGuire R: Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate. Dev Med Child Neurol 1991;33:524-534.
102. Vining EP, Mellitis ED, Dorsen MM, et al: Psychologic and behavioral effects of antiepileptic drugs in children: A double-blind comparison between phenobarbital and valproic acid. Pediatrics 1987;80:165-174.
103. Chamberlain JM, Altieri MA, Futterman C, et al: A prospective, randomized study comparing intramuscular midazolam with intravenous diazepam for the treatment of seizures in children. Pediatr Emerg Care 1997;13:92-94.
104. Scott RC, Besag FM, Neville BG: Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: A randomised trial. Lancet 1999:353:623-626.
105. Appleton R, Sweeney A, Choonara I, et al: Lorazepam versus diazepam in the acute treatment of epileptic seizures and status epilepticus. Dev Med Child Neurol 1995:37:682-688.
106. Chiron C, Dumas C, Jambaque I, et al: Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res 1997;26:389-395.
107. Baram TZ, Mitchell WG, Tournay A, et al: High-dose corticotropin (ACTH) versus prednisone for infantile spasms: A prospective, randomized, blinded study. Pediatrics 1996:97:375-379.
108. Hrachovy RA, Frost JD, Glaze DG: High-dose, long-duration versus low-dose, short-duration corticotropin therapy for infantile spasms. J Pediatr 1994:124:803-806.
109. Yanagaki S, Oguni H, Hayashi K, et al: A comparative study of high-dose and low-dose ACTH therapy for West syndrome. Brain Dev 1999:21:461-467.
110. Dreifuss F, Farwell J, Holmes G, et al: Infantile spasms. Comparative trial of nitrazepam and corticotropin. Arch Neurol 1986:43:1107-1110.
111. Elterman RD, Shields WD, Mansfield KA, Nakagawa J: US Infantile Spasms Vigabatrin Study Group. Randomized trial of vigabatrin in patients with infantile spasms. Neurology 2001:57:1416-1421.
112. Appleton RE, Peters AC, Mumford JP, Shaw DE: Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms. Epilepsia 1999;40:1627-1633.
113. Vigevano F, Cilio MR: Vigabatrin versus ACTH as first-line treatment for infantile spasms: A randomized, prospective study. Epilepsia 1997;38:1270-1274.
114. Trudeau V, Myers S, LaMoreaux L, et al: Gabapentin in naive childhood absence epilepsy: Results from two double-blind, placebo-controlled, multicenter studies. J Child Neurol 1996;11:470-475.
115. Sato S, White BG, Penry JK, et al: Valproic acid versus ethosuximide in the treatment of absence seizures. Neurology 1982;32:157-163.
116. Callaghan N, O'Hare J, O'Driscoll D, et al: Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal). Dev Med Child Neurol 1982;24:830-836.
117. Chiron C, Marchand MC, Tran A, et al: Stiripentol in severe myoclonic epilepsy in infancy: A randomized placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet 2000;356:1638-1642.
118. Rating D, Wolf C, Bast T: Sulthiame as monotherapy in children with benign childhood epilepsy with centrotemporal spikes: A 6-month randomized, double-blind, placebo-controlled study. Sulthiame Study Group. Epilepsia 2000:41:1284-1288.
119. Bourgeois B, Brown LW, Pellock JM: Gabapentin (Neurontin) monotherapy in children with benign childhood epilepsy with centrotemporal spikes (BECTS): A 36-week, double-blind, placebo-controlled study. Epilepsia 1998;39(Suppl 6):163.